FindTrial
Sign In

Development and Validation of a Nomogram for Predicting Blood Pressure Change Failure in Patients with Pheochromocytoma and Concomitant Hypertension after Adrenalectomy

Development and Validation of a Nomogram for Predicting Blood Pressure Change Failure in Patients with Pheochromocytoma and Concomitant Hypertension after Adrenalectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060503
Enrollment
Unknown
Registered
2022-06-03
Start date
2022-05-25
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma

Interventions

Trial group:Hypertension
Control group:Hypertension recovery

Sponsors

ShengJing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic or open unilateral adrenalectomy (unilateral and unilateral tumors) with pathological findings of pheochromocytoma; 2. Limited clinical staging (no adjacent organ invasion or metastasis).

Exclusion criteria

Exclusion criteria: 1. No persistent hypertension, family history of pheochromocytoma or malignant tumor before surgery.

Design outcomes

Primary

MeasureTime frame
Blood pressure;—

Countries

China

Contacts

Public ContactSong Bai

ShengJing Hospital of China Medical University

baisongcmu81@163.com+86 18940255568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026